Lili (Aurélie) Nsongo
Stock Analyst at Leerink Partners
(0.08)
# 4,762
Out of 5,078 analysts
41
Total ratings
9.1%
Success rate
-31.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lili (Aurélie) Nsongo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Rated: Buy | $14 → $15 | $3.47 | +332.28% | 3 | Oct 20, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $19 | $6.68 | +184.43% | 1 | Oct 12, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | $11 | $1.74 | +532.18% | 11 | Dec 15, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $17 | $9.84 | n/a | 18 | Oct 23, 2025 | |
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €3.00 | €8.40 | n/a | 8 | Sep 18, 2025 |
Opus Genetics
Oct 20, 2026
Rated: Buy
Price Target: $14 → $15
Current: $3.47
Upside: +332.28%
REGENXBIO
Oct 12, 2026
Reiterated: Buy
Price Target: $19
Current: $6.68
Upside: +184.43%
Voyager Therapeutics
Dec 15, 2025
Reiterated: Buy
Price Target: $11
Current: $1.74
Upside: +532.18%
Arcturus Therapeutics Holdings
Oct 23, 2025
Reiterated: Buy
Price Target: $17
Current: $9.84
Upside: n/a
Sensorion SA
Sep 18, 2025
Reiterated: Buy
Price Target: €3.00
Current: €8.40
Upside: n/a